Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFβRII

Oncogene

Volumn 19, Issue 32, 2000, Pages 3623-3631

  Go, Cindy ^a   He, Wei ^a   Zhong, Ling ^a   Li, Ping ^a   Huang, Juan ^a   Brinkley, Bill R ^a   Wang, Xiao Jing ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cdk inhibitors, centrosome; Cell cycle progression; Skin carcinogenesis; Transforming growth factor receptor; Transgenic

Indexed keywords

BROXURIDINE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; PROTEIN P27; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CHEMICAL CARCINOGENESIS; EPIDERMIS; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; MITOSIS INDEX; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; TRIXIS;

EID: 0034721099     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203701     Document Type: Article

References (43)

1. Aldaz CM, Conti CJ, Klein-Szanto AJ and Slaga TJ. (1987). Proc. Natl. Sci. USA, 84, 2029-2032.
2. Bertsch S and Marks F. (1982). Cell Tissue Kinet., 15, 81-87.
3. Bottinger EP, Jakubczak JL, Roberts IS, Mumy M, Hemmati P, Bagnall K, Merlino G and Wakefield LM. (1997). EMBO J., 16, 2621-2633.
4. Brinkley BR. (1985). Ann. Rev. Cell. Biol., 1, 145-172.
5. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JV, Markowitz SD, Kinzler KW and Vogelstein B. (1998). Nature, 392, 300-303.
6. Carcamo J, Zentella A and Massague J. (1995). Mol. Cell. Biol., 15, 1573-1581.
7. Chen F and Weinberg RA. (1995). Proc. Natl. Acad. Sci. USA, 92, 1565-1569.
8. Chen RH, Ebner R and Derynck R. (1993). Science, 260, 1335-1338.
9. Conti CJ, Aldaz CM, O'Connell J, Klein-Szanto AJ and Slaga TJ. (1986). Carcinogenesis, 7, 1845-1848.
10. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y and Wang XF. (1995). Proc. Natl. Acad. Sci. USA, 92, 5545-5549.
11. Derynck R. (1994). Trends Biochem. Sci., 19, 548-553.
12. Feng XH, Filvaroff EH and Derynck R. (1995). J. Biol. Chem., 270, 24237-24245.
13. Filmus J and Kerbel RS. (1993). Curr. Opin. Oncol., 5, 123-129.
14. Fynan TM and Reiss M. (1993). Crit. Rev. Oncog., 4, 493-540.
15. Geng Y and Weinberg RA. (1993). Proc. Natl. Acad. Sci. USA, 90, 10315-10319.
16. Glick A, Popescu N, Alexander V, Ueno H, Bottinger E and Yuspa SH. (1999). Proc. Natl. Acad. Sci. USA, 96, 14949-14954.
17. Go C, Li P and Wang XJ. (1999). Cancer Res., 59, 2861-2868.
18. Gorska AE, Joseph H, Derynck R, Moses HL and Serra R. (1998). Cell Growth Differ, 9, 229-238.
19. Greenhalgh DA, Welty DJ, Strickland JE and Yuspa SH. (1989). Mol. Carcinog., 2, 199-207.
20. Hannon GJ and Beach D. (1994). Nature, 371, 257-261.
21. Iacopetta BJ, Welch J, Soong R, House AK, Zhou XP and Hamelin R. (1998). J. Pathol., 184, 390-395.
22. Iavarone A and Massague J. (1997). Nature, 387, 417-422.
23. Imai Y, Tsurutani N, Oda H, Inoue T and Ishikawa T. (1998). Int. J. Cancer, 76, 407-411.
24. Li B, Rosen JM, McMenamin-Balano J, Muller WJ and Perkins AS. (1997). Mol. Cell. Biol., 17, 3155-3163.
25. Lu SL, Akiyama Y, Nagasaki H, Saitoh K and Yuasa Y. (1995). Biochem. Biophys. Res. Commun., 216, 452-457.
26. Lu SL, Kawabata M, Imamura T, Akiyama Y, Nomizu T, Miyazono K and Yuasa Y. (1998). Nat. Genet., 19, 17-18.
27. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW and Vogelstein B. (1995). Science, 268, 1336-1338.
28. Murphy CS, Pietenpol JA, Munger K, Howley PM and Moses HL. (1991). Cold Spring Harb. Symp. Quant. Biol., 56, 129-135.
29. Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J and Park K. (1995). Cancer Res., 55, 5545-5547.
30. Nagahara H, Ezhevsky SA, Vocero-Akbani AM, Kaldis P, Solomon MJ and Dowdy SF. (1999). Proc. Natl. Acad. Sci. USA, 96, 14961-14966.
31. Nagase H, Mao JH and Balmain A. (1999). Proc. Natl. Acad. Sci. USA, 96, 15032-15037.
32. Polyak K. (1996). Biochim. Biophys. Acta., 1242, 185-199.
33. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A. (1994). Genes Dev., 8, 9-22.
34. Satterwhite DJ and Moses HL. (1994). Invasion Metastasis, 14, 309-318.
35. Takenoshita S, Tani M, Nagashima M, Hagiwara K, Bennett WP, Yokota J and Harris CC. (1997). Oncogene, 14, 1255-1258.
36. van Diest PJ, Baak JP, Matze-Cok P, Wisse-Brekelmans EC, van Galen CM, Kurver PH, Bellot SM, Fijnheer J. van Gorp LH and Kwee WS. (1992). Hum. Pathol., 23, 603-607.
37. Venkatasubbarao K, Ahmed MM, Swiderski C, Harp C, Lee EY, McGrath P, Mohiuddin M, Strodel W and Freeman JW. (1998). Genes Chromosomes Cancer, 22, 138-144.
38. Wang D, Song H, Evans JA, Lang JC, Schuller DE and Weghorst CM. (1997a). Carcinogenesis, 18, 2285-2290.
39. Wang XJ, Greenhalgh DA, Bickenbach JR, Jiang A, Bundman DS, Krieg T, Derynck R and Roop DR. (1997b). Proc. Natl. Acad. Sci. USA, 94, 2386-2391.
40. Wang XJ, Greenhalgh DA, Jiang AB, He D, Zhong L, Medina D, Brinkley BR and Roop DR. (1998a). Oncogene, 17, 35-45.
41. Wang XJ, Greenhalgh DA, Jiang A, He D, Zhong L, Medina D, Brinkley BR and Roop DR. (1998b). Mol. Carcinog., 23, 185-192.
42. Wieser R, Attisano L, Wrana JL and Massague J. (1993). Mol. Cell Biol., 13, 7239-7247.
43. Wrana JL, Attisano L, Wieser R, Ventura F and Massague J. (1994). Nature, 370, 341-347.